Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.
Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.
复制标题
DOI:
10.7150/jca.5839
复制
发表时间:
2013
影响因子:
3.9
通讯作者:
Stojadinovic A
中科院分区:
文献类型:
--
作者:
Summers T;Langan RC;Nissan A;Brücher BL;Bilchik AJ;Protic M;Daumer M;Avital I;Stojadinovic A
Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States. Early identification and treatment of pre-cancerous colorectal lesions, or node-negative CRC are highly effective interventions that substantially reduce disease-specific mortality. Colonoscopy remains a highly effective primary screening tool based on its excellent diagnostic accuracy, and its ability to remove pre-cancerous lesions. However, the nature of the procedure limits compliance with colonoscopy intended for population-based CRC screening. A significant advance in the screening and care of these patients could be realized by blood-based biomarkers, which could accurately identify patients at-risk for CRC development whom might benefit from early and/or more frequent surveillance for disease. We reviewed and herein discuss the potential for serum based DNA methylation biomarkers for screening and early detection of CRC.
登录
查看更多内容
影响因子:
10.3
作者:
Glass, Andrew G.;Lacey, James V., Jr.;Hoover, Robert N.
通讯作者:
Hoover, Robert N.
影响因子:
6.2
作者:
Liggett, Thomas;Melnikov, Anatoliy;Levenson, Victor
通讯作者:
Levenson, Victor
影响因子:
--
作者:
Goebel G;Zitt M;Zitt M;Müller HM
通讯作者:
Müller HM
影响因子:
4.7
作者:
Liggett TE;Melnikov A;Yi Q;Replogle C;Hu W;Rotmensch J;Kamat A;Sood AK;Levenson V
通讯作者:
Levenson V
影响因子:
3.7
作者:
Tóth K;Sipos F;Kalmár A;Patai AV;Wichmann B;Stoehr R;Golcher H;Schellerer V;Tulassay Z;Molnár B
通讯作者:
Molnár B